These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 34281095)

  • 1. Role of Quality of Life as Endpoint for Inflammatory Bowel Disease Treatment.
    Calviño-Suárez C; Ferreiro-Iglesias R; Bastón-Rey I; Barreiro-de Acosta M
    Int J Environ Res Public Health; 2021 Jul; 18(13):. PubMed ID: 34281095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crohn's disease and ulcerative colitis. Occurrence, course and prognosis during the first year of disease in a European population-based inception cohort.
    Burisch J
    Dan Med J; 2014 Jan; 61(1):B4778. PubMed ID: 24393595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Impact of Inflammatory Bowel Disease in Canada 2018: Quality of Life.
    Jones JL; Nguyen GC; Benchimol EI; Bernstein CN; Bitton A; Kaplan GG; Murthy SK; Lee K; Cooke-Lauder J; Otley AR
    J Can Assoc Gastroenterol; 2019 Feb; 2(Suppl 1):S42-S48. PubMed ID: 31294384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mucosal healing restores normal health and quality of life in patients with inflammatory bowel disease.
    Casellas F; Barreiro de Acosta M; Iglesias M; Robles V; Nos P; Aguas M; Riestra S; de Francisco R; Papo M; Borruel N
    Eur J Gastroenterol Hepatol; 2012 Jul; 24(7):762-9. PubMed ID: 22517240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of inflammatory bowel disease with infliximab and other anti-tumor necrosis factor alpha therapies.
    Magro F; Portela F
    BioDrugs; 2010 Dec; 24 Suppl 1():3-14. PubMed ID: 21175228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Appropriateness of immunosuppressive drugs in inflammatory bowel diseases assessed by RAND method: Italian Group for IBD (IG-IBD) position statement.
    Caprilli R; Angelucci E; Cocco A; Viscido A; Annese V; Ardizzone S; Biancone L; Castiglione F; Cottone M; Meucci G; Paoluzi P; Papi C; Sturniolo GC; Vecchi M
    Dig Liver Dis; 2005 Jun; 37(6):407-17. PubMed ID: 15893279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Strategies to improve quality of life in adolescents with inflammatory bowel disease.
    Karwowski CA; Keljo D; Szigethy E
    Inflamm Bowel Dis; 2009 Nov; 15(11):1755-64. PubMed ID: 19472359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biological therapy increases the health-related quality of life in patients with inflammatory bowel disease in a clinical setting.
    Holdam AS; Bager P; Dahlerup JF
    Scand J Gastroenterol; 2016; 51(6):706-11. PubMed ID: 26794211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quality of Life--measurement in inflammatory bowel disease.
    Irvine EJ
    Scand J Gastroenterol Suppl; 1993; 199():36-9. PubMed ID: 8171299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fatigue and health-related quality of life in inflammatory bowel disease: results from a population-based study in the Netherlands: the IBD-South Limburg cohort.
    Romberg-Camps MJ; Bol Y; Dagnelie PC; Hesselink-van de Kruijs MA; Kester AD; Engels LG; van Deursen C; Hameeteman WH; Pierik M; Wolters F; Russel MG; Stockbrügger RW
    Inflamm Bowel Dis; 2010 Dec; 16(12):2137-47. PubMed ID: 20848468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a quality-of-life index for pediatric inflammatory bowel disease: dealing with differences related to age and IBD type.
    Griffiths AM; Nicholas D; Smith C; Munk M; Stephens D; Durno C; Sherman PM
    J Pediatr Gastroenterol Nutr; 1999 Apr; 28(4):S46-52. PubMed ID: 10204526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quality of Life in Inflammatory Bowel Diseases (IBDs) Patients after Surgery.
    Di Candido F
    Rev Recent Clin Trials; 2022; 17(4):227-239. PubMed ID: 35959618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evolving primary and secondary endpoints in randomized controlled trials leading to approval of biologics and small molecules in IBD: an historical perspective.
    Allen PB; Bonovas S; Danese S; Peyrin-Biroulet L
    Expert Opin Biol Ther; 2020 Feb; 20(2):151-161. PubMed ID: 31815548
    [No Abstract]   [Full Text] [Related]  

  • 14. The Short Inflammatory Bowel Disease Questionnaire: a quality of life instrument for community physicians managing inflammatory bowel disease. CCRPT Investigators. Canadian Crohn's Relapse Prevention Trial.
    Irvine EJ; Zhou Q; Thompson AK
    Am J Gastroenterol; 1996 Aug; 91(8):1571-8. PubMed ID: 8759664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adherence to medical treatment in inflammatory bowel disease patients.
    Zelante A; De Giorgi A; Borgoni R; Trevisani L; Gallerani M
    Minerva Gastroenterol Dietol; 2014 Dec; 60(4):269-74. PubMed ID: 25384805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current therapeutic approaches in inflammatory bowel disease.
    Sohrabpour AA; Malekzadeh R; Keshavarzian A
    Curr Pharm Des; 2010; 16(33):3668-83. PubMed ID: 21128898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disability and quality of life before and during the COVID-19 outbreak: A cross-sectional study in inflammatory bowel disease patients.
    Azzam NA; Aljebreen A; Almuhareb A; Almadi MA
    Saudi J Gastroenterol; 2020; 26(5):256-262. PubMed ID: 32415045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The place of sphingosine-1-phosphate modulators in the therapy of inflammatory bowel diseases].
    Szymaszkiewicz K; Szymaszkiewicz A; Fichna J
    Postepy Biochem; 2020 Mar; 66(1):42-48. PubMed ID: 33320478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patient-Reported Outcomes of Quality of Life, Functioning, and GI/Psychiatric Symptom Severity in Patients with Inflammatory Bowel Disease (IBD).
    IsHak WW; Pan D; Steiner AJ; Feldman E; Mann A; Mirocha J; Danovitch I; Melmed GY
    Inflamm Bowel Dis; 2017 May; 23(5):798-803. PubMed ID: 28301432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perceived Quality of Care is Associated with Disease Activity, Quality of Life, Work Productivity, and Gender, but not Disease Phenotype: A Prospective Study in a High-volume IBD Centre.
    Gonczi L; Kurti Z; Verdon C; Reinglas J; Kohen R; Morin I; Chavez K; Bessissow T; Afif W; Wild G; Seidman E; Bitton A; Lakatos PL
    J Crohns Colitis; 2019 Sep; 13(9):1138-1147. PubMed ID: 30793162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.